DANVERS, Mass.--(BUSINESS WIRE)-- The final results of the physician-led National Cardiogenic Shock Initiative (NCSI) Study demonstrate a 71% survival to discharge with greater than 90% native heart ...
NaviGate Cardiac Structures Inc. (“NCSI”)announced today that its GATE™ catheter-guided tricuspid atrioventricular valved stent (AVS) was implanted through the jugular vein six weeks ago into a ...
SAN FRANCISCO, CA—A standardized approach that emphasizes early, aggressive treatment of acute MI complicated by cardiogenic shock (AMICS) is producing markedly better survival rates, observational ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback